Skip to main content
Log in

Rates and Predictors of Endoscopic and Clinical Recurrence After Primary Ileocolic Resection for Crohn’s Disease

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background and Aims

The utility of postoperative medical prophylaxis (POMP) and the treatment of mild endoscopic recurrence remain controversial.

Methods

This study is a retrospective review of patients undergoing a primary ileocolic resection for CD at a single academic center. Endoscopic recurrence (ER) was defined using the Rutgeerts score (RS), and clinical recurrence (CR) was defined as symptoms of CD with endoscopic or radiologic evidence of neo-terminal ileal disease.

Results

There were 171 patients who met inclusion criteria. The cumulative probability of ER (RS ≥ i-1) at 1, 2, and 5 years was 29, 51, and 77 %, respectively. The only independent predictors of ER were the absence of POMP (HR 1.50; P = 0.03) and penetrating disease behavior (HR 1.50; P = 0.05). The cumulative probability of CR at 1, 2, and 5 years was 8, 13, and 27 %, respectively. There was a higher rate of clinical recurrence in patients with RS-2 compared to RS-1 on the initial postoperative endoscopy (HR 2.50; P = 0.02). In 11 patients not exposed to POMP with i-1 on initial endoscopy, only 2 patients (18 %) progressed endoscopically during the study period while 5 patients (45 %) regressed to i-0 on subsequent endoscopy without treatment.

Conclusions

Postoperative medical prophylaxis decreased the likelihood of ER while certain phenotypes of CD appear to increase the risk of developing ER and CR. There may be a role for watchful waiting in patients with mild endoscopic recurrence on the initial postoperative endoscopy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347:417–429.

    Article  CAS  PubMed  Google Scholar 

  2. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46.e42–54.e42. (quiz e30).

    Article  Google Scholar 

  3. Waterman M, Xu W, Stempak JM, et al. Distinct and overlapping genetic loci in Crohn’s disease and ulcerative colitis: correlations with pathogenesis. Inflamm Bowel Dis. 2011;17:1936–1942.

    Article  PubMed  Google Scholar 

  4. Mikhailov TA, Furner SE. Breastfeeding and genetic factors in the etiology of inflammatory bowel disease in children. World J Gastroenterol. 2009;15:270–279.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Hansen TS, Jess T, Vind I, et al. Environmental factors in inflammatory bowel disease: a case-control study based on a Danish inception cohort. J Crohns Colitis. 2011;5:577–584.

    Article  PubMed  Google Scholar 

  6. Baumgart DC, Sandborn WJ. Crohn’s disease. The Lancet. 2012;380:1590–1605.

    Article  Google Scholar 

  7. Regueiro MD. Update in medical treatment of Crohn’s disease. J Clin Gastroenterol. 2000;31:282–291.

    Article  CAS  PubMed  Google Scholar 

  8. Scott FI, Osterman MT. Medical management of crohn disease. Clin Colon Rectal Surg. 2013;26:67–74.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Loftus EV Jr, Schoenfeld P, Sandborn WJ. The epidemiology and natural history of Crohn’s disease in population-based patient cohorts from North America: a systematic review. Aliment Pharmacol Ther. 2002;16:51–60.

    Article  PubMed  Google Scholar 

  10. Solberg IC, Vatn MH, Hoie O, et al. Clinical course in Crohn’s disease: results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol Hepatol. 2007;5:1430–1438.

    Article  PubMed  Google Scholar 

  11. Romberg-Camps MJ, Dagnelie PC, Kester AD, et al. Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease. Am J Gastroenterol. 2009;104:371–383.

    Article  CAS  PubMed  Google Scholar 

  12. Cerqueira RM, Lago PM. Clinical factors predictive of Crohn’s disease complications and surgery. Eur J Gastroenterol Hepatol. 2013;25:129–134.

    Article  PubMed  Google Scholar 

  13. Pascua M, Su C, Lewis JD, et al. Meta-analysis: factors predicting post-operative recurrence with placebo therapy in patients with Crohn’s disease. Aliment Pharmacol Ther. 2008;28:545–556.

    Article  CAS  PubMed  Google Scholar 

  14. Olaison G, Smedh K, Sjodahl R. Natural course of Crohn’s disease after ileocolic resection: endoscopically visualised ileal ulcers preceding symptoms. Gut. 1992;33:331–335.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Rutgeerts P, Geboes K, Vantrappen G, et al. Natural history of recurrent Crohn’s disease at the ileocolonic anastomosis after curative surgery. Gut. 1984;25:665–672.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Vantrappen G, Rutgeerts P. Recurrence of Crohn’s lesions in the neoterminal ileum after ileal resection and ileocolonic anastomosis. Verh K Acad Geneeskd Belg. 1990;52:373–382. (discussion 383–385).

    CAS  PubMed  Google Scholar 

  17. Rutgeerts P, Goboes K, Peeters M, et al. Effect of faecal stream diversion on recurrence of Crohn’s disease in the neoterminal ileum. Lancet. 1991;338:771–774.

    Article  CAS  PubMed  Google Scholar 

  18. Cameron JL, Hamilton SR, Coleman J, et al. Patterns of ileal recurrence in Crohn’s disease. A prospective randomized study. Ann Surg. 1992;215:546–551. (discussion 551–552).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Buisson A, Chevaux JB, Allen PB, et al. Review article: the natural history of postoperative Crohn’s disease recurrence. Aliment Pharmacol Ther. 2012;35:625–633.

    Article  CAS  PubMed  Google Scholar 

  20. Ng SC, Lied GA, Arebi N, et al. Clinical and surgical recurrence of Crohn’s disease after ileocolonic resection in a specialist unit. Eur J Gastroenterol Hepatol. 2009;21:551–557.

    Article  PubMed  Google Scholar 

  21. Rutgeerts P. Review article: recurrence of Crohn’s disease after surgery—the need for treatment of new lesions. Aliment Pharmacol Ther. 2006;24:29–32.

    Article  PubMed  Google Scholar 

  22. Ng SC, Kamm MA. Management of postoperative Crohn’s disease. Am J Gastroenterol. 2008;103:1029–1035.

    Article  PubMed  Google Scholar 

  23. De Cruz P, Kamm MA, Prideaux L, et al. Postoperative recurrent luminal Crohn’s disease: a systematic review. Inflamm Bowel Dis. 2012;18:758–777.

    Article  PubMed  Google Scholar 

  24. Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749–753.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Rutgeerts P, Geboes K, Vantrappen G, et al. Predictability of the postoperative course of Crohn’s disease. Gastroenterology. 1990;99:956–963.

    Article  CAS  PubMed  Google Scholar 

  26. Bernell O, Lapidus A, Hellers G. Risk factors for surgery and postoperative recurrence in Crohn’s disease. Ann Surg. 2000;231:38–45.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Gao X, Yang RP, Chen MH, et al. Risk factors for surgery and postoperative recurrence: analysis of a south China cohort with Crohn’s disease. Scand J Gastroenterol. 2012;47:1181–1191.

    Article  PubMed  Google Scholar 

  28. Regueiro M, Kip KE, Baidoo L, et al. Postoperative therapy with infliximab prevents long-term Crohn’s disease recurrence. Clin Gastroenterol Hepatol. 2014;12:1494–1502.

    Article  CAS  PubMed  Google Scholar 

  29. Lopez J, Konijeti GG, Nguyen DD, et al. Natural history of Crohn’s disease following total colectomy and end ileostomy. Inflamm Bowel Dis. 2014;20:1236–1241.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Kono T, Hida N, Nogami K, et al. Prospective postsurgical capsule endoscopy in patients with Crohn’s disease. World J Gastrointest Endosc. 2014;6:88–98.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Malireddy K, Larson DW, Sandborn WJ, et al. Recurrence and impact of postoperative prophylaxis in laparoscopically treated primary ileocolic Crohn disease. Arch Surg. 2010;145:42–47.

    Article  PubMed  Google Scholar 

  32. Tursi A, Elisei W, Picchio M, et al. Comparison of the effectiveness of infliximab and adalimumab in preventing postoperative recurrence in patients with Crohn’s disease: an open-label, pilot study. Tech Coloproctol. 2014;18:1041–1046.

    Article  CAS  PubMed  Google Scholar 

  33. Yamamoto T, Bamba T, Umegae S, et al. The impact of early endoscopic lesions on the clinical course of patients following ileocolonic resection for Crohn’s disease: a 5-year prospective cohort study. United Eur Gastroenterol J. 2013;1:294–298.

    Article  Google Scholar 

  34. Savarino E, Bodini G, Dulbecco P, et al. Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn’s disease: a randomized controlled trial. Am J Gastroenterol. 2013;108:1731–1742.

    Article  CAS  PubMed  Google Scholar 

  35. Lochs H, Mayer M, Fleig WE, et al. Prophylaxis of postoperative relapse in Crohn’s disease with mesalamine: European Cooperative Crohn’s Disease Study VI. Gastroenterology. 2000;118:264–273.

    Article  CAS  PubMed  Google Scholar 

  36. McLeod RS, Wolff BG, Steinhart AH, et al. Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn’s disease. Gastroenterology. 1995;109:404–413.

    Article  CAS  PubMed  Google Scholar 

  37. Prantera C, Scribano ML, Falasco G, et al. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn’s disease: a randomised controlled trial with Lactobacillus GG. Gut. 2002;51:405–409.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Rutgeerts P, Hiele M, Geboes K, et al. Controlled trial of metronidazole treatment for prevention of Crohn’s recurrence after ileal resection. Gastroenterology. 1995;108:1617–1621.

    Article  CAS  PubMed  Google Scholar 

  39. Rutgeerts P, Van Assche G, Vermeire S, et al. Ornidazole for prophylaxis of postoperative Crohn’s disease recurrence: a randomized, double-blind, placebo-controlled trial. Gastroenterology. 2005;128:856–861.

    Article  CAS  PubMed  Google Scholar 

  40. Vaughn BP, Moss AC. Prevention of post-operative recurrence of Crohn’s disease. World J Gastroenterol. 2014;20:1147–1154.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Schwartz M, Regueiro M. Prevention and treatment of postoperative Crohn’s disease recurrence: an update for a new decade. Curr Gastroenterol Rep. 2011;13:95–100.

    Article  PubMed  Google Scholar 

  42. Kotze PG, Yamamoto T. Infliximab versus azathioprine to prevent postoperative recurrence in Crohn’s disease: are all controversial issues defined? J Crohns Colitis. 2013;7:e698.

    Article  PubMed  Google Scholar 

  43. Armuzzi A, Felice C, Papa A, et al. Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn’s disease: an open-label pilot study. J Crohns Colitis. 2013;7:e623–e629.

    Article  PubMed  Google Scholar 

  44. Doherty G, Bennett G, Patil S, Cheifetz A, Moss AC. Interventions for prevention of post-operative recurrence of Crohn’s disease. Cochrane Database Syst Rev. 2009. doi:10.1002/14651858.CD006873.pub2.

    PubMed  Google Scholar 

  45. Cullen G, O’Toole A, Keegan D, et al. Long-term clinical results of ileocecal resection for Crohn’s disease. Inflamm Bowel Dis. 2007;13:1369–1373.

    Article  PubMed  Google Scholar 

  46. Cottone M, Rosselli M, Orlando A, et al. Smoking habits and recurrence in Crohn’s disease. Gastroenterology. 1994;106:643–648.

    Article  CAS  PubMed  Google Scholar 

  47. Simillis C, Jacovides M, Reese GE, et al. Meta-analysis of the role of granulomas in the recurrence of Crohn disease. Dis Colon Rectum. 2010;53:177–185.

    Article  PubMed  Google Scholar 

  48. Simillis C, Yamamoto T, Reese GE, et al. A meta-analysis comparing incidence of recurrence and indication for reoperation after surgery for perforating versus nonperforating Crohn’s disease. Am J Gastroenterol. 2008;103:196–205.

    Article  PubMed  Google Scholar 

  49. Chambers TJ, Morson BC. The granuloma in Crohn’s disease. Gut. 1979;20:269–274.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Caprilli R, Corrao G, Taddei G, et al. Prognostic factors for postoperative recurrence of Crohn’s disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Dis Colon Rectum. 1996;39:335–341.

    Article  CAS  PubMed  Google Scholar 

  51. Greenstein AJ, Lachman P, Sachar DB, et al. Perforating and non-perforating indications for repeated operations in Crohn’s disease: evidence for two clinical forms. Gut. 1988;29:588–592.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Vuitton L, Koch S, Peyrin-Biroulet L. Preventing postoperative recurrence in Crohn’s disease: what does the future hold? Drugs. 2013;73:1749–1759.

    Article  CAS  PubMed  Google Scholar 

  53. van Lent AU, D’Haens GR. Management of postoperative recurrence of Crohn’s disease. Dig Dis. 2013;31:222–228.

    Article  PubMed  Google Scholar 

  54. Cottone M, Orlando A, Viscido A, et al. Review article: prevention of postsurgical relapse and recurrence in Crohn’s disease. Aliment Pharmacol Ther. 2003;17:38–42.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kyle Joshua Fortinsky.

Ethics declarations

Conflict of interest

None of the authors have any conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fortinsky, K.J., Kevans, D., Qiang, J. et al. Rates and Predictors of Endoscopic and Clinical Recurrence After Primary Ileocolic Resection for Crohn’s Disease. Dig Dis Sci 62, 188–196 (2017). https://doi.org/10.1007/s10620-016-4351-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-016-4351-7

Keywords

Navigation